Aptose Biosciences Changes Auditors
Ticker: APTOF · Form: 8-K · Filed: Apr 21, 2025 · CIK: 882361
Sentiment: neutral
Topics: auditor-change, administrative
Related Tickers: APTO
TL;DR
APTO just swapped PwC for EY as their auditor, effective April 15, 2025.
AI Summary
Aptose Biosciences Inc. announced on April 15, 2025, a change in its certifying accountant. The company has dismissed PricewaterhouseCoopers LLP as its independent registered public accounting firm and has appointed Ernst & Young LLP as its new principal accountant. This change is effective immediately.
Why It Matters
A change in auditors can sometimes signal underlying issues or a strategic shift within a company, warranting investor attention.
Risk Assessment
Risk Level: low — This filing reports a routine administrative change in the company's auditors and does not contain information that inherently increases risk.
Key Players & Entities
- Aptose Biosciences Inc. (company) — Registrant
- PricewaterhouseCoopers LLP (company) — Former Certifying Accountant
- Ernst & Young LLP (company) — New Certifying Accountant
- April 15, 2025 (date) — Effective Date of Change
FAQ
When was the change in certifying accountant effective?
The change in certifying accountant was effective April 15, 2025.
Who was Aptose Biosciences Inc.'s former certifying accountant?
Aptose Biosciences Inc.'s former certifying accountant was PricewaterhouseCoopers LLP.
Who is Aptose Biosciences Inc.'s new principal accountant?
Aptose Biosciences Inc.'s new principal accountant is Ernst & Young LLP.
Did Aptose Biosciences Inc. have any disagreements with PricewaterhouseCoopers LLP?
The filing does not state any disagreements with PricewaterhouseCoopers LLP.
What is the company's fiscal year end?
The company's fiscal year end is December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 21, 2025 regarding Aptose Biosciences Inc. (APTOF).